R Nowack

Summary

Affiliation: University of Mannheim
Country: Germany

Publications

  1. ncbi Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis
    R Nowack
    V th Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Zweibrücken, Germany
    Am J Kidney Dis 34:364-73. 1999
  2. ncbi Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement
    R Nowack
    5th Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Germany
    J Am Soc Nephrol 10:1965-71. 1999
  3. ncbi Upregulation of CD14 and CD18 on monocytes In vitro by antineutrophil cytoplasmic autoantibodies
    R Nowack
    Vth Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Germany
    J Am Soc Nephrol 11:1639-46. 2000
  4. ncbi ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis
    R Nowack
    Fifth Medical Clinic (Nephrology, Endocrinology, University-Clinic Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany
    Nephrol Dial Transplant 16:1631-7. 2001

Collaborators

Detail Information

Publications4

  1. ncbi Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis
    R Nowack
    V th Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Zweibrücken, Germany
    Am J Kidney Dis 34:364-73. 1999
    ....
  2. ncbi Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement
    R Nowack
    5th Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Germany
    J Am Soc Nephrol 10:1965-71. 1999
    ..Long-term treatment with MMF in these diseases is attractive because of its low toxicity. MMF will have to be studied further and compared with cyclophosphamide or azathioprine maintenance therapy in randomized trials...
  3. ncbi Upregulation of CD14 and CD18 on monocytes In vitro by antineutrophil cytoplasmic autoantibodies
    R Nowack
    Vth Medical Clinic Nephrology, Endocrinology, University Clinic Mannheim, Germany
    J Am Soc Nephrol 11:1639-46. 2000
    ..Upregulation of CD14 and CD18 on monocytes by ANCA suggests a pathogenetic role of ANCA monocyte interactions in systemic vasculitis...
  4. ncbi ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis
    R Nowack
    Fifth Medical Clinic (Nephrology, Endocrinology, University-Clinic Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany
    Nephrol Dial Transplant 16:1631-7. 2001
    ..CONCLUSIONS: There is no rationale for serial measurements of ANCA in AASV. For changes of therapy, the ANCA parameters should only be used in conjunction with clinical information...